Childhood Atopic Dermatitis Linked to IBD Risk Childhood Atopic Dermatitis Linked to IBD Risk
A prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 10, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news

Why So Many Dogs Have Allergies Now
Every day, itchy dogs shuffle into Elizabeth Falk’s veterinary office. Some can’t stop chewing their feet or scratching their bellies. Others have red, smelly ears, or rashes on their skin. All are intensely uncomfortable because of environmental allergies. “They’re sitting in the waiting room, and everyone else is backing away out of fear that it’s contagious,” she says. “It’s super busy helping as many as we can.” Until recently, Falk was a veterinary dermatologist at Cornell University Veterinary Specialists, where she saw about 15 allergic pets a day and was booked ...
Source: TIME: Health - March 27, 2024 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized healthscienceclimate Source Type: news

AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
MONDAY, March 18, 2024 -- Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news

Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks
The encouraging long-term efficacy and safety associated with nemolizumab (IL-31 inhibitor) in prurigo nodularis was supported by a second set of data showing long-term benefit in atopic dermatitis.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 15, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news

Topical Nonsteroid Gets High Marks for Youngsters With Atopic Dermatitis
(MedPage Today) -- SAN DIEGO -- Once-daily topical therapy for small children with atopic dermatitis (AD) produced rapid improvement with good tolerability, a large randomized trial showed. Evidence of improvement occurred within the first week... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 15, 2024 Category: Dermatology Source Type: news

Atopic Dermatitis in Children Tied to Learning, Memory Difficulties
TUESDAY, March 12, 2024 -- Pediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with neurodevelopmental comorbidities, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 12, 2024 Category: Pharmaceuticals Source Type: news

Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children? Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?
The analysis included children aged 17 years or younger without intellectual disability or autism.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 7, 2024 Category: Psychiatry Tags: Dermatology Source Type: news

Kids' Atopic Dermatitis Tied to Higher Risks of Learning, Memory Difficulties
(MedPage Today) -- Pediatric atopic dermatitis was associated with increased risks of learning and memory difficulties, especially in kids with comorbid neurodevelopmental disorders, a cross-sectional study suggested. In a weighted sample of over... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 6, 2024 Category: Psychiatry Source Type: news

Review Highlights Evidence of Climate Change Effects on AD Review Highlights Evidence of Climate Change Effects on AD
Atopic dermatitis " could serve as a case study for climatic impacts on health, " the authors emphasized in their paper.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 1, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news

Most Effective Atopic Dermatitis Treatments May Also Be Most Harmful
New research aids physicians in selecting best option for patients MILWAUKEE, Feb. 21, 2024 The most effective treatment for improving outcomes for patients with atopic dermatitis may also be the riskiest, however the effectiveness of competing treatments varies according to new research... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 21, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news

PH Labelling of Skin Cleansers Can Lead to Better Options for People with Atopic Dermatitis
Liquid synthetic detergents are more likely to be acidic than other cleansers, making them a good option for people with atopic dermatitis. MILWAUKEE, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Atopic dermatitis patients may find better results using liquid synthetic detergents according to new... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 20, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news

Tapinarof Under FDA Review for Treating Atopic Dermatitis Tapinarof Under FDA Review for Treating Atopic Dermatitis
Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 16, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news

Non-Lesional Filaggrin Expression is Predictive of Asthma Development in Children with Atopic Dermatitis
Low Filaggrin expression in children aged 2 to 3 years old is a significant predictor of school-age asthma. MILWAUKEE, Feb. 14, 2024 /PRNewswire-PRWeb/ -- Filaggrin (FLG) expression in non-lesional skin and observations of the skin barrier can lead to early diagnosis for children with... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 14, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news

Galderma Announces Regulatory Filing Acceptance for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in the U.S. and EU
Zug, Switzerland– February 14, 2024– Galderma today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Applications for nemolizumab for the treatment of prurigo nodularis and for adolescents... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - February 14, 2024 Category: Drugs & Pharmacology Source Type: news

Early-Life Skin Microbiome and Metabolome Signatures Could Predict Atopic Dermatitis in Infants
New research shows identifiable bacterial species in the skin microbiota of infants can lead to early detection of atopic dermatitis. MILWAUKEE, Feb. 9, 2024 /PRNewswire-PRWeb/ -- Early skin microbiome and metabolome signatures can be predictive of atopic dermatitis in infants aged 6 to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 9, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news